NSW Tuberculosis Surveillance Report 2023: Outcomes

​​​ On this page

  1. Outcomes for both multidrug-resistant (MDR) and non-MDR tuberculosis cases in NSW, 2023
  2. Contact investigation outcomes from tuberculosis pulmonary smear positive cases diagnosed in NSW, 2023

Outcomes for both multidrug-resistant (MDR) and non-MDR tuberculosis cases in NSW, 2022

​The majority of TB cases successfully completed TB treatment in 2022 (90%). The treatment outcome is unable to be assessed when people transfer overseas (3% of cases), and a small number of cases die from causes not related to TB while on treatment (4% of cases). ​

Treatment outcomeNon-MDR casesMDR cases
Completed treatment478 (90%)8 (89%)
Defaulted7 (1%)0 (0%)
Treatment failure1 (<1%)0 (0%)
Died due to TB3 (1%)1 (11%)
Died of other or unknown causes 21 (4%) 0 (0%)
Transferred overseas to complete treatment16 (3%)0 (0%)
Remains on extensive treatment3 (1%)0 (0%)
Total529 (100%)9 (100%)

Contact investigation outcomes from TB pulmonary smear positive cases diagnosed in NSW, 2023

​There were 172​4 contacts identified in NSW in 2023 from TB pulmonary smear positive cases, 62% of those completed contact screening for TB. 

 

Notes

Data for this report was extracted from Notifiable Conditions Records for Epidemiology and Surveillance, NSW Ministry of Health on 24 September 2024.

Laboratory 2023 report Past reports

Current as at: Monday 13 January 2025
Contact page owner: Communicable Diseases